Changes in the virulence of Mycobacterium avium after passage through embryonated hens' eggs

FEMS Microbiology Letters

Volumn 190, Issue 2, 2000, Pages 267-272

  Long, Earl G ^a   Ewing Jr , Edwin P ^b   Bartlett, Jeanine H ^c   Horsburgh Jr , C Robert ^d   Birkness, Kristin A ^a   Yakrus, Mitch A ^a   Newman, Gale W ^e   Quinn, Frederick D ^a  

^a Div Parasitic Dis Natl Ctr I   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Embryonated hen egg; Mycobacterium avium; Pathogenesis; Virulence

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CHICK EMBRYO; CHORIOALLANTOIS; EMBRYO; GRANULOMA; HUMAN; HUMAN CELL; MESODERM; MONONUCLEAR CELL; MORTALITY; MYCOBACTERIUM AVIUM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY FAILURE;

ALLANTOIS; ANIMALS; CELLS, CULTURED; CHICK EMBRYO; CHORION; CULTURE TECHNIQUES; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; VIRULENCE;

ACTINOBACTERIA (CLASS); ANIMALIA; BACTERIA (MICROORGANISMS); GALLUS GALLUS; MYCOBACTERIUM; MYCOBACTERIUM AVIUM; UNCULTURED ACTINOMYCETE;

EID: 0034666573     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00346-3     Document Type: Article

References (20)

1. Birkness K.A., Swords W.E., Huang P.-H., White E.H., Dezzutti C.S., Lal R.B., Quinn F.D. Observed differences in virulence-associated phenotypes between a human clinical isolate and a veterinary isolate of Mycobacterium avium. Infect. Immun. 67:1999;4895-4901.
2. Bryant, E. (1984) Biology and diseases of birds. In: Laboratory Animal Medicine (Fox, J.G., Cohen, B.J. and Loew, F.M., Eds.), pp. 399-426. Academic Press, Orlando, FL.
3. Centers for Disease Control (1985) Revision of the case definition of acquired immunodeficiency syndrome for national reporting - United States, MMWR 34, 373-375.
4. Edwards L.B., Acquaviva F.A., Livesay V.T., Cross F.W., Palmer C.E. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am. Rev. Respir. Dis. 99:1969;1-132.
5. Friedland J.S., Hartley J.C., Hartley C.G.C., Shattock R.J., Griffin G.E. Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection. Clin. Exp. Immunol. 100:1995;233-238.
6. Furney S.K., Skinner P.S., Roberts A.D., Appelberg R., Orme I.M. Capacity of Mycobacterium avium isolates to grow well or poorly in murine macrophages resided in their ability to induce secretion of tumor necrosis factor. Infect. Immun. 60:1992;4410-4413.
7. Hamson S.J., Thompson J., Mosq M.T., Portaels F., Green E.P., Hermon-Taylor J., McFadden J.J. DNA probes demonstrate a single highly conserved strain of Mycobacterium avium infecting AIDS patients. Lancet. i:1989;65-68.
8. Horsburgh C.R. Jr. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. New Engl. J. Med. 324:1991;1332-1338.
9. Ichiyama S., Shimokata K., Tsukamura M. The isolation of Mycobacterium avium complex from soil, water, and dust. Microbiol. Immunol. 32:1988;733-739.
10. Inderleid C.B., Kemper C.A., Bermudez L.E.M. The Mycobacterium avium complex. Clin. Microbiol. Rev. 6:1993;266-310.
11. Kindler V.A.P., Grau G.E., Piguet P.F., Vassali P. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell. 56:1989;731-740.
12. Klatt E.C., Jensen D.F., Meyer P.R. Pathology of Mycobacterium avium- intracellulare infection in acquired immunodeficiency syndrome. Hum. Pathol. 18:1987;709-713.
13. Meissner G., Anz E. Sources of Mycobacterium avium complex infection resulting in human disease. Am. Rev. Respir. Dis. 166:1977;1057-1064.
14. Michelini-Norris M.B., Blanchard D.K., Pearson C.A., Djeu J.Y. Differential release of interleukin (IL)-1a, IL-1β, and IL-6 from normal human monocytes stimulated with a virulent and avirulent isogenic variant of Mycobacterium avium-intracellulare complex. J. Infect. Dis. 165:1992;702-709.
15. Plum G., Clark-Curtiss J.E. Induction of Mycobacterium avium gene expression following phagocytosis by human macrophages. Infect. Immun. 62:1994;476-483.
16. Reddy V.M., Parikh K., Luna-Herrera J., Falkingham J.O. III, Brown S., Gangadharam P.R.J. Comparison of virulence of Mycobacterium avium complex (MAC) strains isolated from AIDS and non-AIDS patients. Microb. Pathogen. 16:1994;121-130.
17. Shiratsuchi H., Johnson J.L., Ellner J.J. Mycobacterium avium: pathogenicity in HIV-1 infection. Microbiology. 145:1994;230-236.
18. Utt E.A., Brousal J.P., Kikuta-Oshima L.C., Quinn F.D. The identification of bacterial gene expression differences using mRNA-based isothermal subtractive hybridization. Can. J. Microbiol. 41:1995;152-156.
19. Wallace R.J. Jr. Nontuberculous mycobacteria: a love affair with increasing importance. Infect. Dis. Clin. North Am. 1:1987;677-686.
20. Wong B., Edwards F.F., Kiehn T.E., Whimbey E., Donnelley H., Bernard E.M., Gold J.W.M., Armstrong D. Continuous high-grade Mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am. J. Med. 78:1985;35-40.